Check-Cap (NASDAQ:CHEK) Coverage Initiated by Analysts at StockNews.com

StockNews.com initiated coverage on shares of Check-Cap (NASDAQ:CHEK) in a report issued on Monday. The brokerage issued a sell rating on the medical research company’s stock.

Check-Cap Trading Down 1.8 %

Shares of NASDAQ CHEK opened at $2.18 on Monday. The firm has a market cap of $12.75 million, a price-to-earnings ratio of -0.72 and a beta of 0.28. The stock has a fifty day simple moving average of $2.24 and a two-hundred day simple moving average of $2.62. Check-Cap has a 1-year low of $1.27 and a 1-year high of $4.63.

Institutional Investors Weigh In On Check-Cap

Several large investors have recently added to or reduced their stakes in the company. Sabby Management LLC bought a new position in Check-Cap during the first quarter worth about $91,000. Virtu Financial LLC lifted its stake in shares of Check-Cap by 363.4% during the 2nd quarter. Virtu Financial LLC now owns 224,696 shares of the medical research company’s stock valued at $69,000 after buying an additional 176,207 shares in the last quarter. Nantahala Capital Management LLC bought a new position in Check-Cap in the 4th quarter worth approximately $69,000. Susquehanna International Group LLP purchased a new position in Check-Cap in the 1st quarter valued at approximately $57,000. Finally, Citadel Advisors LLC raised its holdings in Check-Cap by 51.2% during the 3rd quarter. Citadel Advisors LLC now owns 141,319 shares of the medical research company’s stock valued at $41,000 after acquiring an additional 47,868 shares during the period. Hedge funds and other institutional investors own 1.07% of the company’s stock.

Check-Cap Company Profile

Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation.